{"id":"https://openalex.org/A5113435751","orcid":"https://orcid.org/0009-0005-8330-0053","observed_orcids":["https://orcid.org/0009-0005-8330-0053"],"display_name":"Jianing Zhong","raw_author_names":["Jianing Zhong"],"full_name":"Jianing Zhong","works_count":6,"cited_by_count":34,"summary_stats":{"2yr_mean_citedness":5.666666666666667,"h_index":4,"i10_index":1},"ids":{"openalex":"https://openalex.org/A5113435751","orcid":"https://orcid.org/0009-0005-8330-0053","observed_orcids":["https://orcid.org/0009-0005-8330-0053"]},"affiliations":[{"institution":{"id":"https://openalex.org/I97018004","ror":"https://ror.org/00f54p054","display_name":"Stanford University","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]},"years":[2026,2025,2024]}],"last_known_institutions":[{"id":"https://openalex.org/I97018004","ror":"https://ror.org/00f54p054","display_name":"Stanford University","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"topics":[{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","count":5,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","count":4,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","count":3,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","count":2,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","count":1,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","value":8.28e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","value":2.27e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","value":1.62e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","value":7.2e-06,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","value":5e-06,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.9041000008583069},{"id":"134459356","wikidata":"https://www.wikidata.org/wiki/Q4274835","display_name":"Ubiquitin ligase","score":0.7692999839782715},{"id":"55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","score":0.5340999960899353},{"id":"86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","score":0.34075701236724854},{"id":"104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","score":0.12874886393547058}],"counts_by_year":[{"year":2024,"works_count":2,"oa_works_count":2,"cited_by_count":14},{"year":2025,"works_count":3,"oa_works_count":2,"cited_by_count":19},{"year":2026,"works_count":1,"oa_works_count":1,"cited_by_count":1}],"display_name_alternatives":["Jianing Zhong"],"block_key":"j zhong","works_api_url":"https://api.openalex.org/works?filter=author.id:A5113435751","updated_date":"2026-10-15T12:44:11","created_date":"2024-10-29T00:00:00"}